Du Fang-Zhi, Zhang Hai-Ni, Li Jing-Jing, Zheng Zhi-Ju, Zhang Xu, Zhang Rui-Li, Wang Qian-Qiu
Department of Clinical Prevention and Control of STD, Institute of Dermatology, Chinese Academy of Medical Science and Peking Union Medical College, National Center for STD Control, China Centers for Disease Control and Prevention, Nanjing, China.
Department of Dermatology, The Fifth People's Hospital of Suzhou, Suzhou, China.
Front Med (Lausanne). 2022 May 13;9:894841. doi: 10.3389/fmed.2022.894841. eCollection 2022.
Considered the increased threaten of neurosyphilis in China, a review on cases reported in the literature to describe the clinical epidemiological characteristics of neurosyphilis cases, may be beneficial to the early detection and management strategies of neurosyphilis for clinicians. We searched the literature on Chinese neurosyphilis cases published from January 1, 2009 to December 31, 2021, described their clinical epidemiological characteristics and calculated the prevalence of neurosyphilis amongst other associated diseases, according to the individual study criteria. A total of 284 studies including 7,486 neurosyphilis cases were included. No meta-analysis was performed due to the heterogeneity of the data. Among 149 case reports and 93 retrospective case series studies, the main clinical manifestation of 3,507 neurosyphilis cases was cerebral parenchymal syphilis (57.3%), followed by asymptomatic neurosyphilis (16.7%), meningovascular syphilis (13.6%), meningitis syphilis (7.7%) and ocular syphilis (2.8%), etc. In addition, the initial diagnosis was incorrect in 53.2% patients, and the most frequent misdiagnoses were mental disorders (31.0%), stroke (15.9%), cognitive impairment (9.0%), etc. The positive or abnormal rates of cerebrospinal fluid non-treponemal and treponemal tests, white blood cell counts and protein concentrations were 74.2%, 96.2%, 61.5%, and 60.9%, respectively. Aqueous penicillin was the first choice for treatment in 88.3% cases, and 81.7% and 50.0% patients had response in the improvement of symptoms and serological effective in CSF, respectively. Among 26 studies on neurosyphilis patients amongst other associated diseases, the prevalence of neurosyphilis amongst central nervous system infectious diseases, syphilis-associated neurological symptoms, serofast status, coinfected with human immunodeficiency virus were 10.6%-30.1%, 23.2%-35.5%, 9.8%-56.1%, and 8.9%, respectively. In summary, the lack of early detection of neurosyphilis cases remains a clinical challenge. The high rate of misdiagnosis and high prevalence of neurosyphilis amongst associated diseases strongly remind clinicians to focus on the early detection among suspected cases. Besides, the standard treatment regimen and long-term follow-up, which complied with guideline should be provided. Further prospective studies are urgent to better delineate the clinical epidemiological characteristics of neurosyphilis in China.
考虑到中国神经梅毒威胁的增加,对文献报道的病例进行综述以描述神经梅毒病例的临床流行病学特征,可能有助于临床医生对神经梅毒进行早期检测和管理策略。我们检索了2009年1月1日至2021年12月31日发表的关于中国神经梅毒病例的文献,根据个体研究标准描述其临床流行病学特征,并计算神经梅毒在其他相关疾病中的患病率。共纳入284项研究,包括7486例神经梅毒病例。由于数据的异质性,未进行荟萃分析。在149例病例报告和93项回顾性病例系列研究中,3507例神经梅毒病例的主要临床表现为脑实质梅毒(57.3%),其次是无症状神经梅毒(16.7%)、脑膜血管梅毒(13.6%)、梅毒性脑膜炎(7.7%)和眼梅毒(2.8%)等。此外,53.2%的患者初始诊断错误,最常见的误诊为精神障碍(31.0%)、中风(15.9%)、认知障碍(9.0%)等。脑脊液非梅毒螺旋体和梅毒螺旋体检测、白细胞计数及蛋白浓度的阳性或异常率分别为74.2%、96.2%、61.5%和60.9%。88.3%的病例首选水剂青霉素治疗,81.7%和50.0%的患者症状改善及脑脊液血清学有效。在26项关于神经梅毒患者与其他相关疾病的研究中,神经梅毒在中枢神经系统感染性疾病、梅毒相关神经症状、血清固定状态、合并人类免疫缺陷病毒感染中的患病率分别为10.6%-30.1%、23.2%-35.5%、9.8%-56.1%和8.9%。总之,神经梅毒病例缺乏早期检测仍然是一个临床挑战。误诊率高以及神经梅毒在相关疾病中的高患病率强烈提醒临床医生关注疑似病例中的早期检测。此外,应提供符合指南的标准治疗方案和长期随访。迫切需要进一步的前瞻性研究以更好地描绘中国神经梅毒的临床流行病学特征。